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b Cambridge Vascular Unit, Cambridge University Hospitals NHS Foundation, Cambridge, UKThe ECAR study is the third randomised trial that has failed
to demonstrate any survival advantage for patients with
ruptured AAA treated by an endovascular stent-grafting
technique. Although of different designs, both IMPROVE1
and the Amsterdam aneurysm study2 essentially came to
the same conclusion of no overall mortality beneﬁt. The
randomised controlled trial ﬁndings conﬂict with those of
the numerous cohort studies, which have demonstrated a
survival beneﬁt for EVAR.3 In attempting to explain these
conﬂicting ﬁndings, the most important factor appears to be
patient selection. A recent meta-analysis identiﬁed that
although EVAR conferred a signiﬁcant beneﬁt over open
repair in most cohort studies, these studies were at a high
risk of bias.3 More speciﬁcally, patients are often assigned
to EVAR when haemodynamically stable and with favour-
able aortic anatomy, introducing a well-deﬁned selection
bias.4
Randomised trials in the emergency setting are difﬁcult
to design and conduct. The ECAR study has a number of
important limitations that reduce its overall impact. The
patients randomised in the trial were a highly selected
cohort of the overall population of patients presenting to
trial centres with a rAAA. In fact only 20% of patients, those
who were haemodynamically stable and anatomically suit-
able for EVAR, were randomised. The interventions and
outcomes of the majority (80%) including those who were
not offered any intervention were not reported. In this
highly selected group it could have been anticipated that
outcomes would be good, and therefore basing the power
calculation on a 40% open repair mortality is hard to justify.
This combined with the failure to complete recruitment,
resulted in the ECAR study being underpowered.
It is also worth considering why centres failed to recruit.
Certainly the entry criteria (stable and EVAR-friendly anat-
omy) were restrictive, and ruptured AAA appears to be a
waning disease, but were there other reasons? The impact
of the lenient credentialing of trial centres in the ECAR may
have inﬂuenced patient outcomes. Patients waited some
considerable time (2.9 hours) to receive an EVAR comparedDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2015.03.028
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http://dx.doi.org/10.1016/j.ejvs.2015.03.040with open repair (1.3 hours), and almost three-quarters of
patients were treated with an AUI EVAR conﬁguration
(despite their stability), suggesting that centres may not
have been as expert in delivering emergency EVAR as they
were with open repair.
The principal factor-inﬂuencing outcome of RAAA ap-
pears to be aortic anatomy. Evidence from Dick et al.5
suggests that outcomes for open repair are signiﬁcantly
better in those patients who are anatomically suitable for
EVAR, and furthermore suggests that borderline anatomical
suitability confers improved outcomes over patients who
are not suitable for EVAR. The recent data from IMPROVE6
reported that infra-renal neck length is an important factor
affecting outcome after RAAA surgery. It is not wholly sur-
prising that a longer neck confers advantages, not only in
those patients undergoing REVAR but also in those under-
going open repair by providing a suitable infra-renal clamp
site.
So, if, as the randomised trials suggest, EVAR confers no
mortality beneﬁt over open repair in anatomically suitable
patients, then do any patients beneﬁt from EVAR?
IMPROVE suggests that females (and those undergoing
EVAR under local anaesthesia) may have better outcomes.
There is, however, another group who may potentially
beneﬁt from EVAR - those patients previously offered no
intervention for their ruptured AAA. This group is difﬁcult to
deﬁne, as “turn down rates” are often not reported, and
account for over 40% of patients presenting with ruptured
AAA in the UK.7 Evidence from cohort studies suggests that
EVAR is offered to older patients who otherwise may not be
offered any intervention.8 And offering intervention to a
greater proportion of patients presenting with ruptured
AAA will have the greatest impact on reducing overall
mortality rates. Delivery of an effective 24/7 emergency
EVAR service in vascular centres is going to be a key
component in delivering improved outcomes for patients
presenting with ruptured AAA.REFERENCES
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